PEPG PepGen Inc: Pre-Move Stock Alert

PepGen Inc., a clinical-stage biotechnology company, develops oligonucleotide therapeutics for severe neuromuscular diseases, with key candidates targeting Duchenne muscular dystrophy (DMD) and myotonic dystrophy.

At the time of the alert, PepGen Inc. had 32.69 million shares outstanding and a float of 12.38 million shares. The company’s market capitalization was approximately $70 million, with an average daily volume of 250,000 shares. However, on the day of the alert, trading volume surged to 109,229,500 shares, marking an extraordinary 109,000% increase. This sharp rise in volume provided members with a prime opportunity to capitalize on a day trading strategy using ChatterFlow AI alerts, which tracks real-time social chatter momentum.

PepGen Inc. Stock Alert Stats
Shares Outstanding 32.69 Million
Float 12.38 Million
Market Capitalization $70 Million
Average Daily Volume 250,000 Shares
Volume for the Day 109,229,500 Shares
Percentage Increase in Volume 109,000% Increase
Short Position 852,550 Shares
Short Percentage of Float 5%
Niche Industry Neurological Biotechnology
Movement for First Alert to Peak of Day 109% Surge

The surge in this biotech company’s stock was fueled by positive initial results from the ongoing FREEDOM-DM1 trial, igniting investor enthusiasm and drawing significant media coverage. ChatterFlow users, leveraging AI-driven alerts, acted quickly—buying in at a low price before the stock soared 109%—to capitalize on the gains.